Patient info

Losartan Potassium/Hydrochlorothiazide 50 mg/12.5 mg film-coated tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
No longer supplied
Medicine strength:
100 mg / 12.5 mg
Still supplied:
The same active substances, strength and form in the NHS Dictionary of Medicines and Devices (dm+d). Ask your pharmacist or doctor before changing to another make.
Contains active substances:

Patient leaflet - Losartan Potassium/hydrochlorothiazide 100 mg / 12.5 mg film-coated tablets

1. What Losartan Potassium/Hydrochlorothiazide is and what it is used for

Losartan potassium belongs to a group of medicines called angiotensin-II receptor antagonists. These cause the blood vessels to relax which in turn lowers the blood pressure.

Hydrochlorothiazide belongs to a group of medicines called diuretics (water tablets). Hydrochlorothiazide works by making the kidneys pass more water and salt. This also helps to reduce blood pressure.

Losartan Potassium/Hydrochlorothiazide 50 mg/12.5 mg Film-coated Tablets:

These tablets are used to treat high blood pressure. The combination of losartan and hydrochlorothiazide is a suitable alternative for those people who would otherwise have to be treated with losartan potassium and hydrochlorothiazide given as separate tablets.

Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Film-coated Tablets:

These tablets are used to treat high blood pressure in patients who have not responded sufficiently to treatment with Losartan Potassium/Hydrochlorothiazide 50 mg/12.5 mg Film-coated Tablets.

1.3.1.3 Package Leaflet

2. What you need to know before you take Losartan Potassium/Hydrochlorothiazide

Do not take Losartan Potassium/Hydrochlorothiazide if you:

  • are allergic to losartan, hydrochlorothiazide or to any of the other ingredients of this medicine (listed in section 6).
  • are allergic to sulphonamide derived substances (e.g. other thiazides, some antibacterial medicines such as co-trimoxazole, ask your doctor if you are not sure).
  • are more than 3 months pregnant. (It is also better to avoid Losartan Potassium/Hydrochlorothiazide in early pregnancy – see pregnancy section).
  • have severely impaired liver function.
  • have severely impaired kidney function or your kidneys are not producing any urine.
  • have low potassium, low sodium or high calcium levels which cannot be corrected by treatment.
  • are suffering from gout.
  • have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren.

If you think any of the above conditions apply to you, consult your doctor or pharmacists.

Warnings and precautions

Talk to your doctor or pharmacist before taking Losartan Potassium/Hydrochlorothiazide.

You must tell your doctor if you think you are (or might become) pregnant. Losartan Potassium/Hydrochlorothiazide is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).

It is important to tell your doctor before taking Losartan Potassium/Hydrochlorothiazide if you:

  • have previously suffered from swelling of the face, lips, throat or tongue.
  • take diuretics (water pills).
  • are on a salt-restricted diet.
  • have or have had severe vomiting and/or diarrhoea.
  • have heart failure.
  • have impaired liver function (see sections 2 “Do not take Losartan Potassium/Hydrochlorothiazide” ).
  • have narrow arteries to your kidneys (renal artery stenosis) or only have one functioning kidney, or you have recently had a kidney transplant.
  • are on haemodialysis.
  • have narrowing of the arteries (atherosclerosis), angina pectoris (chest pain due to poor heart function).
  • have ‘aortic or mitral valve stenosis’ (narrowing of the valves of the heart) or ‘hypertrophic cardiomyopathy’ (a disease causing thickening of heart muscle).
  • are diabetic.

    1.3.1.3 Package Leaflet

  • have had gout.
  • have or have had an allergic condition, asthma or a condition that causes joint pain, skin rashes and fever (systemic lupus erythematosus).
  • experienced breathing or lung problems (including inflammation or fluid in the lungs) following hydrochlorothiazide intake in the past. If you develop any severe shortness of breath or difficulty breathing after taking [Nationally completed name], seek medical attention immediately
  • have high calcium or low potassium levels or you are on a low potassium diet.
  • need an anaesthetic (even at the dentist) or before surgery, or if you are going to have tests to check your parathyroid function, you must tell the doctor or medical staff that you are taking Losartan Potassium/Hydrochlorothiazide tablets.
  • have primary hyperaldosteronism (a syndrome associated with increased secretion of the hormone aldosterone by the adrenal gland, caused by an abnormality within the gland).
  • have had skin cancer or if you develop an unexpected skin lesion during the treatment. Treatment with hydrochlorothiazide, particularly long term use with high doses, may increase the risk of some types of skin and lip cancer (non-melanoma skin cancer). Protect your skin from sun exposure and UV rays while taking Losartan Potassium/ Hydrochlorothiazide.
  • experience a decrease in vision or eye pain. These could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase of pressure in your eye and can happen within hours to weeks of taking Losartan Potassium/Hydrochlorothiazide This can lead to permanent vision loss, if not treated. If you earlier have had a penicillin or sulphonamide allergy, you can be at higher risk of developing this
  • are taking any of the following medicines used to treat high blood pressure:

    • an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems.
    • aliskiren.

Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.

See also information under the heading “Do not take Losartan Potassium/Hydrochlorothiazide if you”.

Talk to your doctor if you experience abdominal pain, nausea, vomiting or diarrhoea after taking Losartan Potassium/Hydrochlorothiazide. Your doctor will decide on further treatment. Do not stop taking Losartan Potassium/Hydrochlorothiazide on your own.

Children and adolescents

The safety and efficacy of Losartan Potassium/Hydrochlorothiazide in children and adolescents under the age of 18 years have not been established. Losartan Potassium/Hydrochlorothiazide should not be given to children and adolescents.

Talk to your doctor if you are an athlete taking a doping test, as Losartan Potassium/Hydrochlorothiazide contains an active substance that can cause positive results in a doping test.

1.3.1.3 Package Leaflet

Other medicines and Losartan Potassium/Hydrochlorothiazide

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Your doctor may need to change your dose and/or take other precautions if you are taking:

  • lithium (a medicine for treatment of mania or depression)
  • potassium supplements
  • potassium-containing salt substitutes
  • potassium-sparing medicines
  • other diuretics (water tablets)
  • some laxatives
  • medicines for the treatment of gout
  • medicines to control heart rhythm
  • medicines for diabetes (oral agents or insulins)
  • medicines to reduce your blood pressure
  • steroids
  • medicines to treat cancer
  • pain killers
  • arthritis medicines
  • medicines to treat fungal infections
  • resins used for high cholesterol (e.g. colestyramine)
  • medicines which relax muscles
  • sleeping tablets
  • opioid medicines (e.g. morphine)
  • medicines called pressor amines (e.g. adrenaline)
  • glycyrrhizin (found in liquorice root)
  • an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Losartan Potassium/Hydrochlorothiazide ” and “Warnings and precautions”)

Please also inform your doctor you are taking Losartan Potassium/Hydrochlorothiazide if you will be undergoing a radiographic procedure and will be given iodine contrast media.

Losartan Potassium/Hydrochlorothiazide with food and drink

You are advised not to drink alcohol whilst taking these tablets: alcohol and Losartan Potassium/Hydrochlorothiazide may increase each other’s effects.

Dietary salt in excessive quantities may counteract the effect of Losartan Potassium/Hydrochlorothiazide.

Losartan Potassium/Hydrochlorothiazide may be taken with or without food.

Do not take grapefruit juice while taking Losartan Potassium/Hydrochlorothiazide.

1.3.1.3 Package Leaflet

Pregnancy and breast-feeding

Pregnancy

You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking Losartan Potassium/Hydrochlorothiazide before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Losartan Potassium/Hydrochlorothiazide. Losartan Potassium/Hydrochlorothiazide is not recommended in pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.

Breast-feeding

Tell your doctor if you are breast-feeding or about to start breast-feeding. Losartan Potassium/Hydrochlorothiazide is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

When you begin treatment with this medicine, you should not perform tasks which may require special attention (for example, driving an automobile or operating dangerous machinery) until you know how you tolerate your medicine.

Losartan Potassium/Hydrochlorothiazide contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

3. How to take Losartan Potassium/Hydrochlorothiazide

Always take Losartan Potassium/Hydrochlorothiazide exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Your doctor will decide on the appropriate dose of Losartan Potassium/Hydrochlorothiazide depending on your condition and whether you are taking other medicines. It is important to continue taking Losartan Potassium/Hydrochlorothiazide for as long as your doctor prescribes it in order to maintain smooth control of your blood pressure.

Take the tablet with a glass of water. It may be taken with or without food.

Use in adults

Losartan Potassium/Hydrochlorothiazide 50 mg/12.5 mg Film-coated Tablets:

The usual dose is one tablet once daily. If necessary your doctor may increase your dose to a maximum of 2 tablets once daily or one tablet of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Film-coated Tablets once daily.

1.3.1.3 Package Leaflet

Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Film-coated Tablets:

The usual dose is one tablet once daily.

Use in the elderly

Dose adjustment is not usually necessary for the elderly.

Use in kidney impairment and haemodialysis

In case of moderate kidney problems dose adjustment is not usually necessary. However, do not take Losartan Potassium/Hydrochlorothiazide if your kidney function is severely impaired. Losartan Potassium/Hydrochlorothiazide is not recommended for patients on haemodialysis.

Use in liver impairment

Losartan Potassium/Hydrochlorothiazide should be used with caution in patients with history of mild to moderate liver impairment. However, do not take Losartan Potassium/Hydrochlorothiazide if your liver function is severely impaired (see section 2. “Do not take Losartan Potassium/Hydrochlorothiazide if you”).

Use in children and adolescents

Losartan Potassium/Hydrochlorothiazide should not be given to children and

adolescents under 18 years of age.

.

Use in black patients

Dose adjustment may be necessary as Losartan Potassium/Hydrochlorothiazide may be less effective in black patients than in non-black patients.

If you take more Losartan Potassium/Hydrochlorothiazide than you should

In case of an overdose, contact your doctor immediately so that medical attention may be given promptly. Overdose can cause a drop in blood pressure, palpitations, slow pulse, changes in blood composition, and dehydration.

If you forget to take Losartan Potassium/Hydrochlorothiazide

Do not take a double dose to make up for a forgotten tablet. Take your next dose at the usual time.

If you stop taking Losartan Potassium/Hydrochlorothiazide

Always consult your doctor, if you wish to stop taking this medicine. Even if you feel well, it may be necessary to continue taking this medicine.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

1.3.1.3 Package Leaflet

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you experience the following, stop taking Losartan Potassium/Hydrochlorothiazide and tell your doctor immediately or go to the casualty department of your nearest hospital:

A severe allergic reaction (rash, itching, swelling of the face, lips, mouth or throat that may cause difficulty in swallowing or breathing).

This is a serious but rare side effect, which affects more than 1 out of 10,000 patients but fewer than 1 out of 1,000 patients. You may need urgent medical attention or hospitalisation.

Acute respiratory distress (signs include severe shortness of breath, fever, weakness, and confusion), this is a very rare side effect (may affect up to 1 in 10,000 people).

The following side effects have been reported:

Common (may affect up to 1 in 10 people):

  • cough, upper airway infection, congestion in the nose, sinusitis, sinus disorder
  • diarrhoea, abdominal pain, nausea, indigestion
  • muscle pain or cramps, leg pain, back pain
  • insomnia, headache, dizziness
  • weakness, tiredness, chest pain
  • increased potassium levels (which can cause an abnormal heart rhythm), decreased haemoglobin levels
  • changes in kidney function including kidney failure
  • too low sugar in the blood (hypoglycaemia)

Uncommon (may affect up to 1 in 100 people):

  • anaemia, red or brownish spots on the skin (sometimes especially on the feet, legs, arms and buttocks, with joint pain, swelling of the hands and feet and stomach pain), bruising, reduction in white blood cells, clotting problems, reduced number of platelets
  • loss of appetite, high level of uric acid in the blood or frank gout, high blood sugar level, abnormal level of electrolyte in the blood
  • anxiety, nervousness, panic disorder (recurring panic attacks), confusion, depression, abnormal dreams, sleep disorders, sleepiness, memory impairment
  • pins and needles or similar sensations, pain in the extremities, trembling, migraine, fainting
  • blurred vision, burning or stinging in the eyes, conjunctivitis, worsening eyesight, seeing things in yellow
  • ringing, buzzing, roaring or clicking in the ears, vertigo
  • low blood pressure, which may be associated with changes in posture (feeling light-headed or weak when you stand up, angina (chest pain), abnormal heartbeat, cerebrovascular accident (TIA, “mini-stroke”), heart attack, palpitations
  • inflammation of blood vessels, which is often associated with a skin rash or bruising

    1.3.1.3 Package Leaflet

  • sore throat, breathlessness, bronchitis, pneumonia, water on the lungs (which causes difficulty breathing), nosebleed, runny nose, congestion
  • constipation, obstipation, wind, stomach upsets, stomach spasms, vomiting, dry mouth, inflammation of a salivary gland, toothache
  • jaundice (yellowing of the eyes and skin), inflammation of the pancreas
  • hives, itching, inflammation of the skin, rash, redness of the skin, sensitivity to light, Lyell syndrome (skin looking as if it were burnt and peeling off), dry skin, flushing, sweating, hair loss
  • pain in the arms, shoulders, hips, knees or other joints, joint swelling, stiffness, muscle weakness
  • frequent urination including at night, abnormal kidney function including inflammation of the kidneys, urinary infection, sugar in the urine
  • decreased sexual appetite, impotence
  • swelling of the face, localized swelling (oedema), fever

Rare (may affect up to 1 in 1,000 people):

  • hepatitis (inflammation of the liver), abnormal liver function tests
  • intestinal angioedema: a swelling in the gut presenting with symptoms like abdominal pain, nausea, vomiting and diarrhoea

Not known (frequency cannot be estimated from the available data):

  • flu-like symptoms
  • unexplained muscle pain with dark (tea-colored) urine (rhabdomyolysis)
  • low levels of sodium in the blood (hyponatraemia)
  • generally feeling unwell (malaise)
  • disturbed taste (dysgeusia)
  • skin and lip cancer (non-melanoma skin cancer)
  • short-sightedness
  • decrease in vision or pain in your eyes due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma)

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via the Yellow Card Scheme (www.mhra.gov.uk/yellowcard) or search for MHRA Yellow Card in the Google play or Apple App store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Losartan Potassium/Hydrochlorothiazide

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton/ bottle/ blister after “EXP”. The expiry date refers to the last day of that month.

1.3.1.3 Package Leaflet

Losartan Potassium/Hydrochlorothiazide 50 mg/12.5 mg Film-coated Tablets:

Blister: Store below 30°C.

Bottle: Store below 30°C. Keep the bottle tightly closed in order to protect from moisture.

Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Film-coated Tablets:

Blister: Store below 30°C.

Bottle: Keep the bottle tightly closed in order to protect from moisture.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Losartan Potassium/Hydrochlorothiazide contains

  • The active substance(s) are losartan potassium and hydrochlorothiazide.

Each film-coated tablet contains 50 mg losartan potassium and 12.5 mg hydrochlorothiazide.

Each film-coated tablet contains 100 mg losartan potassium and 25 mg hydrochlorothiazide.

  • The other ingredients are:

Tablet core: lactose monohydrate, cellulose (microcrystalline), maize starch (pregelatinized), magnesium stearate, silica (colloidal anhydrous).

Tablet film-coating: hypromellose, hydroxypropylcellulose, iron oxide yellow (E 172), titanium oxide (E 171), macrogol (400) (for 100 mg/25 mg only), talc (for 100 mg/25 mg only)

What Losartan Potassium/Hydrochlorothiazide looks like and contents of the pack

Losartan Potassium/Hydrochlorothiazide 50 mg/12.5 mg Film-coated Tablets are light yellow, round and biconvex film-coated tablets with a diameter of 8 mm.

Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Film-coated Tablets are light yellow, round and biconvex film-coated tablets with a diameter of 10 mm.

The film-coated tablets are packed in aluminium foil blisters or plastic bottles with or without a child-resistant screw cap.

Blister: 7, 10, 14, 28, 30, 50, 56, 60, 84, 90, 98 and 100 film-coated tablets

Blister (unit dose): 50 film-coated tablets

Bottle: 100, 250 film-coated tablets

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

1.3.1.3 Package Leaflet

Marketing Authorisation Holder

Sandoz Limited

Park View, Riverside Way

Watchmoor Park

Camberley, Surrey

GU15 3YL

United Kingdom

Manufacturer

Lek Pharmaceuticals d.d., Verovskova 57, SI-1526 Ljubljana, Slovenia or

Lek S.A., Ul. Domaniewska 50 C, 02- 672 Warsaw, Poland or

Salutas Pharma GmbH, Otto von Guericke Allee 1, 39179 Barleben, Germany or

Lek Pharmaceuticals d.d., Trimlini 2 D, 9220 Lendava, Slovenia..

This leaflet was last revised in 10/2025.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 04416/1198

Last revision stated in the text: October 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Losartan Potassium/hydrochlorothiazide 100 mg / 12.5 mg film-coated tablets

Active substances Losartan, Hydrochlorothiazide
Strength 100 mg / 12.5 mg
Pharmaceutical form Oral tablet
Losartan Potassium/Hydrochlorothiazide 100 mg/12.5 mg is a white, round, biconvex, film coated tablets, embossed with 100 and 12.5 on one side.
How is it taken Oral
Excipients Silicified microcrystalline cellulose, Silica colloidal anhydrous, Croscarmellose sodium, Silica, Magnesium stearate, Hypromellose, Hydroxypropyl Cellulose, Titanium dioxide (E171)
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 2 years
Shelf life after first opening:
Bottle: 6 months
Storage Blisters: Do not store above 25 °C. Keep in the original packaging. HDPE bottle: Do not store above 25°C. Keep in the original packaging. Keep the bottle tightly closed in order to protect from moisture.
Drug group (ATC) Agents acting on the renin-angiotensin system; Angiotensin II antagonists and diuretics
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09D Angiotensin II receptor blockers (ARBs), combinations
        1. C09DA Angiotensin II receptor blockers (ARBs) and diuretics
          1. C09DA01 losartan and diuretics
Marketing authorisation PL 04416/1198 (first authorised 6 September 2011)
Marketing authorisation holder Sandoz Limited
Codes BNF 02050502

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.